MAgnetic Gastrointestinal Universal Septotome: a Safety and Feasibility Study (MAGUS)

NACompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

February 19, 2020

Primary Completion Date

September 15, 2021

Study Completion Date

September 15, 2021

Conditions
Diverticulum, EsophagealPost Gastric Surgery Syndrome
Interventions
DEVICE

MAGUS

"An upper endoscopy will be performed with the use of fluoroscopy. The MAGUS will be placed under fluoroscopy. The good positioning and the absence of any complications will be confirmed by gastroscopy.~An injection of contrast agent will be done to be sure of the correct positioning and that no complications was happened.~The patient will be kept overnight, with liquid food for 2 and mashed food up to 7 days post procedure"

Trial Locations (1)

1070

Hopital Erasme, Brussels

All Listed Sponsors
lead

Erasme University Hospital

OTHER

NCT04480216 - MAgnetic Gastrointestinal Universal Septotome: a Safety and Feasibility Study (MAGUS) | Biotech Hunter | Biotech Hunter